Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Medical Tech, Phone App Companies Partner on Wound Care

A company making wound care products is collaborating with a developer of mobile apps and analytics to design a more advanced diagnostics system for wounds. . . . → Read More: Medical Tech, Phone App Companies Partner on Wound Care

Celgene Acquires Cancer Drug Start-Up in $7B Deal

The biopharmaceutical company Celgene Corp. is acquiring Impact Biomedicines Inc., a developer of drugs to treat a type of blood-related cancer, in a deal valued as much as $7 billion. . . . → Read More: Celgene Acquires Cancer Drug Start-Up in $7B Deal

Biotech, Microsoft Partner on Immune System Diagnostics

A company that analyzes immune system genomics is collaborating with Microsoft Corporation to develop early-stage disease diagnostics. . . . → Read More: Biotech, Microsoft Partner on Immune System Diagnostics

RNA Therapies Start-Up Raises $55.3M in Early Funds

A start-up company creating treatments for inherited diseases that target faulty RNA transcribed from genetic codes is raising $55.3 million in its first venture funding round. . . . → Read More: RNA Therapies Start-Up Raises $55.3M in Early Funds

Cell Engineering Company Launches, Raises $4.7 Million

A company designing biological circuits with techniques derived from computer-assisted design like those used in semiconductors is starting up in Cambridge, Massachusetts. . . . → Read More: Cell Engineering Company Launches, Raises $4.7 Million

Agriculture Tech Start-Up Accelerator to Open

A group supporting start-up companies and entrepreneurs developing new technologies in food and agriculture plans to begin next month in Minneapolis, Minnesota. . . . → Read More: Agriculture Tech Start-Up Accelerator to Open

Cell Programming Company Raises $49.5M in Early Funds

A start-up enterprise creating add-on treatments that program the effects of cell and gene therapies is raising $49.5 million in its first venture funding round. . . . → Read More: Cell Programming Company Raises $49.5M in Early Funds

Novartis Acquires Nuclear Meds Developer in $3.9B Deal

Drug maker Novartis is purchasing a company that develops therapies and diagnostics using radio isotopes for neuroendocrine and other cancers. . . . → Read More: Novartis Acquires Nuclear Meds Developer in $3.9B Deal

Multi-Drug Resistance Antibiotic Developer to Issue IPO

A three year-old company making new antibiotics to treat infections resistant to earlier antibiotics plans to raise some $75 million in its initial public stock offering. . . . → Read More: Multi-Drug Resistance Antibiotic Developer to Issue IPO

Lilly, CureVac Partner on RNA Cancer Drugs in $1.8B Deal

Drug maker Eli Lilly and Company and biotechnology company CureVac AG agreed to develop a series of cancer immunotherapies based on CureVac’s messenger RNA technology. . . . → Read More: Lilly, CureVac Partner on RNA Cancer Drugs in $1.8B Deal